Week of July 12, 2022 | Vol. 11, Issue 28
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
August 27-29, 2022 - Boston, MA
September 22-23, 2022 - New Brunswick, NJ
October 12, 2022 - Charlotte, NC
October 24-26, 2022 - Leipzig, Germany
November 1-3, 2022 - Messe Frankfurt, Germany
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
4 transactions totaling $1,270 million

Supplies, Equipment & Services
28 transactions totaling $1,585 million

Healthcare IT & Managed Care
4 transactions

Healthcare Facilities & Distributors
15 transactions totaling $5,833 million
PRIVATE PLACEMENTS
Pharma & Biotech
24 transactions totaling $562 million

Supplies, Equipment & Services
17 transactions totaling $392 million

Healthcare IT & Managed Care
9 transactions totaling $230 million

Healthcare Facilities & Distributors
0 transactions
PUBLIC OFFERINGS
Pharma & Biotech
5 transactions totaling $62 million

Supplies, Equipment & Services
4 transactions totaling $65 million

Healthcare IT & Managed Care
1 transaction

Healthcare Facilities & Distributors
0 transactions
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.



Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Aman
M&A / Capital Advisory |OTC | Branded Consumer Health

Project Gateway
Sell-side | Pharma | Generic Pharmaceuticals

Project Panther
Sell-side| CDMO | Consumer Health and Medical Device
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines
Contract Pharma - July 7, 2022
The Medicine Maker brought together Tanner Pharma Group's Georg Schulz and other industry experts to discuss the trends and challenges affecting clinical trials and what can be done to make a difference. Watch here.
TannerLAC has received registration approval for i.Mune TBNK® in Peru, with registration pending in Colombia, Ecuador, Brazil and Mexico. i.Mune TBNK® is a revolutionary IVD product supporting immunodeficient patients. Read more.
As only the second person hired to join the Tanner team, Carolina has seen firsthand the evolution of the company and the growth of the Tanner family. The journey to where the company is today wasn’t easy, but when you’re devoted, easy isn’t necessary. Read more of Carolina's story here.
In her previous line of work, Gaby Bedoya was not so known by her name as she was by her customer rep number. When she came to Tanner, that all changed. Read more of Gaby's story here.
Let's Connect!
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.